By Jessica Preston, Harvey Jenner, Alexandra Weiss For many rare diseases, progress towards the development of new therapies and cures is stymied by several factors, including a lack of disease understanding compounded by small patient populations, challenges to correctly diagnosing and identifying patients for trials, a lack of clearly defined clinical endpoints, and difficulties in Learn More